GENinCode plc (GENI) ORD GBP0.01
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
GENinCode inks partnership with DC's MedStar Health
19 July 2023 10:42
(Sharecast News) - Predictive generics specialist GENinCode announced a collaboration with MedStar Health on Wednesday - a prominent 10-hospital health system in the Washington, DC area of the United States.
-
GENinCode prepares for US revenue as California licence granted
3 January 2023 17:56
(Sharecast News) - Predictive genetics specialist GENinCode announced California state licensing approval and CLIA certification of its Irvine laboratory on Tuesday, enabling it to provide its products for...
-
GENinCode inks collaboration with largest US medical school
23 March 2022 15:31
(Sharecast News) - Cardiovascular genetics company GENinCode announced a collaboration with the Indiana University School of Medicine (IU) on Wednesday - the largest medical school in the United States.
-
GENinCode enters cholesterol collaboration with Cumbria health network
15 March 2022 13:35
(Sharecast News) - Cardiovascular genetics company GENinCode announced a collaboration with the Academic Health Science Network for the North East and North Cumbria (AHSN NENC) on Tuesday, to pilot the use...
-
GENinCode reports success in NHS trial of cholesterol test
8 February 2022 15:37
(Sharecast News) - Predictive genetics technology company GENinCode announced on Tuesday the successful completion of its NHS clinical study, and positive results for its 'Lipid inCode' test for...
-
Genincode moving towards 'a number of important milestones'
25 November 2021 11:36
(Sharecast News) - Predictive genetics company Genincode said on Thursday that it was now moving towards "a number of important milestones" which will drive its growth and profile over the coming...
Company announcements Announcements
-
Grant of Options & Surrender of Existing Options
26 April 2024 14:30
GENinCode
-
CARDIO inCode-Score® US study publication
4 April 2024 10:44
GENinCode
-
New NICE Guidance for Ovarian Cancer
21 March 2024 10:58
GENinCode
-
Holding(s) in Company
9 February 2024 10:00
GENinCode
-
Holding(s) in Company
15 January 2024 07:00
GENinCode
-
Holding(s) in Company
11 January 2024 14:49
GENinCode
-
Holding(s) in Company
11 January 2024 14:30
GENinCode
-
Result of GM and Total Voting Rights
9 January 2024 13:30
GENinCode
-
Result of Retail Offer
28 December 2023 07:00
GENinCode
-
Result of Placing and Subscription
21 December 2023 18:25
GENinCode
-
Retail Offer
21 December 2023 16:59
GENinCode
-
Placing and Subscription
21 December 2023 16:55
GENinCode
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.